The nation of Zimbabwe has declined a substantial US health deal valued at $367m (£272m) over five years over the United States' insistence on sensitive data.
The decision came to light following a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesperson has since stated that the United States was seeking biological samples for research and profit while refused to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further talks to find a deal agreeable to all parties so the nation's vital HIV programme can continue.
Broader Context
This development comes after a similar case in Kenya, where a court suspended a similar deal with the US following legal challenges were raised about the safety of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and accountability.
According to reports, Sixteen African countries have to date signed these new agreements, representing over $18.3bn of fresh investment.
Specifics of the Declined Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving HIV treatment via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – such as new medicines or tests – that might result from that shared data," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery without any certainty that the final treatments would be available to our population should a future pandemic arise."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures already set up through the global organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is intended to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage continued dialogue with our American counterparts on how subsequent co-operation might be designed in a manner that honours the independence and interests of both nations."
Health Experts Response
A leading public health body stated it recognised the government's concerns, but urged that negotiations must proceed considering a large portion of the country's HIV programmes depended on foreign aid.
"Where specific concerns arise, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it commented.
This impasse highlights the ongoing tensions between accepting vital international aid and safeguarding local interests in an ever more interconnected world.